Brucella Melitensis
US-FDASourced from openFDA
GET
/api/v1/drug/brucella-melitensisIndications
Sourced from openFDA- USES: • For the temporary relief of symptoms including: • fever • sweats • malaise • headache • back pain • neck pain • malodorous sweat • gut inflammation These statements are based upon homeopathic principles. They have not been reviewed by the Food and Drug Administration.ICD-10: R51.9
Dosage & administration
Sourced from openFDADIRECTIONS: 1-10 drops under the tongue, 3 times a day or as directed by a health professional. Consult a physician for use in children under 12 years of age.
Warnings & precautions
Sourced from openFDAIf pregnant or breast-feeding, ask a health professional before use. Keep out of reach of children. In case of overdose, contact a physician or Poison Control Center right away. Tamper Evident: Sealed for your protection. Do not use if seal is broken or missing.
Literature
Recent PubMed references pinned to Brucella Melitensis as a MeSH major topic. Citations link to pubmed.ncbi.nlm.nih.gov.
- Pathogen-Mimicking Nanovaccine Induces Potent Humoral and Cellular Immunity against Brucella.ACS applied materials & interfaces · 2026 · Tian W, Yin H, Shen L, et al.PMID 42171617DOI 10.1021/acsami.5c25207
- Integrating epidemiology with genomic tracing to uncover concealed transmission networks in a brucellosis outbreak, Shandong, China.Frontiers in cellular and infection microbiology · 2026 · Huangfu C, Wang M, Fan J, et al.PMID 42093768DOI 10.3389/fcimb.2026.1794629
- A novel indirect ELISA based on BP26 mAb to differentiate Brucella melitensis M5-90BPΔ26 vaccine immunization.Analytical biochemistry · 2026 · Cui Y, Liu S, Cai G, et al.PMID 42092575DOI 10.1016/j.ab.2026.116144
- Impact of inactivation methods on biosafety and antigen reactivity of Brucella melitensis from the perspective of Astral-DIA proteomics based on antibody immunoprecipitation mass spectrometry.PLoS neglected tropical diseases · 2026 · Liu Y, Ge J, Song G, et al.PMID 41920853DOI 10.1371/journal.pntd.0013397
- Comprehensive genomic identification of essential genes required for Brucella melitensis intracellular survival during macrophage infection.Scientific reports · 2026 · Jiang Z, Gao J, Liu M, et al.PMID 41917383DOI 10.1038/s41598-026-46186-6
- Biological characteristics, human cell interaction mechanisms, and differential clinical outcomes of infection by Brucella melitensis, Brucella abortus, Brucella suis, and Brucella canis.Archives of microbiology · 2026 · Cheng Z, Li J, Wang Y, et al.PMID 41724843DOI 10.1007/s00203-026-04800-1
- Brucella-infected macrophage-derived microparticles enhance the host anti-Brucella acquired immune response.Veterinary microbiology · 2026 · Zhang Y, Yuan J, Wu A, et al.PMID 41666696DOI 10.1016/j.vetmic.2026.110930
- Identification and Characterization of Outer Membrane Proteins and Membrane Spanning Protein Complexes in Brucella melitensis.Proteins · 2026 · Kapoor J, Panda A, Naqvi I, et al.PMID 41582728DOI 10.1002/prot.70118
Frequently asked questions
- What is Brucella Melitensis used for?
- According to FDA labeling, Brucella Melitensis carries indications including: USES: • For the temporary relief of symptoms including: • fever • sweats • malaise • headache • back pain • neck pain • malodorous sweat • gut inflammation These statements are based upon homeopathic principles. They have not been reviewed by the Food and Drug Administration.. This is a reference summary of labeled uses, not medical advice or a treatment recommendation.
Note. Data for
brucella-melitensis is illustrative MVP content compiled from public sources. pharmacopeia is for educational and informational use only and is not a substitute for professional medical advice.